Clinical Trials Sponsored by Premier Health

Total 50367 results

Premier Specialists, Australia

Recruiting

Development and Validation of an Investigator Global Assessment Score for Keratosis Pilaris

Keratosis Pilaris

Australia
Premier Specialists, Australia

Recruiting

Validation of 5-Point Investigator Global Assessments for Pemphigus

Pemphigus

Australia, Bulgaria, Greece, Iran, Islamic Republic of, Israel, Singapore, Turkey
Virginia Commonwealth University
VA Premier Health

Completed

Barriers to Treatment in Obese Adolescents

Obesity

United States
Premier Specialists, Australia

Unknown

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

Epidermolysis Bullosa Simplex | Epidermolysis Bullosa Simplex Kobner | Weber-Cockayne Syndrome

Australia
Premier Specialists, Australia

Active, not recruiting

Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo (TILDVIT-1227)

Skin Diseases | Vitiligo | Hypopigmentation | Skin and Connective Tissue Diseases | Pigmentation Disorder | Biologic

Australia
Tonix Pharmaceuticals, Inc.
Premier

Completed

A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine (PREVENTION)

Chronic Migraine | Chronic Migraine, Headache | Chronic Migraine Without Aura | Aura Migraine

United States
Guardant Health, Inc.
Premier Research Group plc

Active, not recruiting

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode (ECLIPSE)

Colorectal Cancer

United States
Premier Specialists, Australia
Steritas

Active, not recruiting

Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBDs)

Glucocorticoids Toxicity | Autoimmune Bullous Dermatosis

Australia
AstraZeneca
Premier HealthCare Solutions Inc.

Recruiting

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care (ANCHOR)

Asthma

United States
Innocoll
Premier Research Group plc

Completed

Safety and Efficacy of CollaRx® Bupivacaine Implant in Men After Open Laparotomy Herniorrhaphy

Postoperative Pain | Inguinal Hernia | Herniorrhaphy

United States
Innocoll
Premier Research Group plc

Completed

Efficacy, Safety and Pharmacokinetic Profile of a Collagen Bupivacaine Implant in Men After Open Mesh Herniorrhaphy

Postoperative Pain | Inguinal Hernia

United States
Innocoll
Premier Research Group plc

Completed

Efficacy and Safety of the CollaRx Bupivacaine Implant Compared to the ON-Q Painbuster Following Abdominal Hysterectomy

Pain, Postoperative

United States
Innocoll
Premier Research Group plc

Terminated

Efficacy and Safety of A Collagen Bupivacaine Implant in Patients After Gastrointestinal Surgery

Pain, Postoperative

United States
Innocoll
Premier Research Group plc

Completed

Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll Implant

Hernioplasty

United States
Premier Health
Dartmouth-Hitchcock Medical Center; Parkinson's Disease Foundation

Completed

The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's Disease (PDExercise)

Parkinson Disease

United States
Innocoll
Premier Research Group plc

Completed

Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With a Mild Infection of a Foot Ulcer

Diabetic Foot Ulcer

United States
Innocoll
Premier Research Group plc

Completed

The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers

Diabetic Foot Ulcer

United States
Octapharma
Premier Research Group plc

Completed

A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases

Primary Immunodeficiency Diseases

United States
Innocoll
Premier Research Group plc

Terminated

Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer

Diabetic Foot Ulcer

United States
Innocoll
Premier Research Group plc

Recruiting

Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair

Postoperative Pain | Inguinal Hernia

United States
Organogenesis
Premier Research Group plc

Active, not recruiting

Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

Knee Osteoarthritis

United States
Innocoll
Premier Research Group plc

Completed

Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy

Postoperative Pain

United States
Innocoll
Premier Research Group plc

Completed

Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant Laparoscopic Inguinal or Umbilical Herniorrhaphy

Postoperative Pain | Hernia

United States
Ophirex, Inc.
Premier Research Group plc

Terminated

Study of Varespladib in Patients Hospitalized With Severe COVID-19 (STAIRS)

Coronavirus Disease 2019 | Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2

United States
Duchesnay Inc.
Premier Research Group plc

Terminated

A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents (PED-301)

Morning Sickness

United States
ReAlta Life Sciences, Inc.
Premier Research Group plc

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia (STAR)

Hypoxic-Ischemic Encephalopathy

United States
Premiere Research Institute
GlaxoSmithKline

Completed

Treximet Early Intervention Adolescent Migraine (TEAM)

Migraine

United States
Cingulate Therapeutics
Premier Research Group plc

Active, not recruiting

Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301

ADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit Hyperactivity

United States
Novan, Inc.
Premier Research Group plc

Completed

A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum

Molluscum Contagiosum

United States
Genfit
Premier Research Group plc; Naturalpha

Completed

Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)

Non-Alcoholic Steatohepatitis (NASH)

United States, Belgium, France, Germany, Italy, Netherlands, Romania, Spain, United Kingdom
University of Miami
Premier Research Labs

Completed

The Effect of Methylated Vitamin B Complex on Depression

Depression

United States
AstraZeneca
Iqvia Pty Ltd; Premier Inc.

Withdrawn

IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the US (IKANOS)

COPD

United States
Ophirex, Inc.
Premier Research Group plc

Completed

Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite (BRAVO)

Snakebites | Envenoming | Envenoming, Snake | Envenomation, Snake

United States, India
Duchesnay Inc.
Premier Research Group plc

Completed

The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy

Nausea and Vomiting of Pregnancy

United States
Evgen Pharma
Premier Research Group plc

Completed

SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer (STEM)

Breast Neoplasm

United Kingdom, Belgium, France, Spain
Paion UK Ltd.
Premier Research Group plc

Completed

A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy

Bronchoscopy

United States
Liquidia Technologies, Inc.
Premier Research Group plc

Completed

Single Ascending Dose Study of Two Liquidia Bupivacaine Formulations

Acute Pain

Denmark
Cassava Sciences, Inc.
Premier Research Group plc

Active, not recruiting

Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease (REFOCUS-ALZ)

Alzheimer Disease

United States, Korea, Republic of, Canada, Puerto Rico
Tonix Pharmaceuticals, Inc.
Premier Research Group plc

Active, not recruiting

Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens (COVID-19 DTH)

Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2

United States
Innocoll
Duke University; Premier Research Group plc

Completed

Safety and Efficacy of an Antibiotic Implant in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Infection

Cardiac Surgery | Sternal Wound Infection

United States
Innocoll
Duke University; Premier Research Group plc

Completed

A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound Infection

Surgical Wound Infection | Colorectal Surgery

United States
West-Ward Pharmaceutical
Premier Research Group plc

Completed

Study of Oral Morphine Sulfate Administration in Pediatric Subjects

Pain, Postoperative

United States
Paion UK Ltd.
Premier Research Group plc

Completed

Multiple Dose Safety and Efficacy Study Evaluating CNS 7056 Versus Midazolam in Patients Undergoing Colonoscopy

Sedation

United States
Wex Pharmaceuticals Inc.
Premier Research Group plc

Terminated

The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment (TTX-CINP-201)

Pain | Neuropathic Pain | Peripheral Neuropathy

United States
Intensity Therapeutics, Inc.
Premier Research Group plc

Not yet recruiting

A Study to Investigate Efficacy & Safety of INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) (INVINCIBLE-3)

Sarcoma,Soft Tissue
HEM Pharma Inc.
Premier Research Group plc

Not yet recruiting

HEM1036 Phase 2 Study in Low Anterior Resection Syndrome

LARS - Low Anterior Resection Syndrome
Cassava Sciences, Inc.
Premier Research Group plc

Active, not recruiting

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease (RETHINK-ALZ)

Alzheimer Disease

United States, Australia, Canada
Tris Pharma, Inc.
Premier Research Group plc

Completed

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

ADHD

United States
Vyne Therapeutics Inc.
Premier Research Group plc

Completed

A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Facial Papulopustular Rosacea

United States
Vyne Therapeutics Inc.
Premier Research Group plc

Completed

A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Facial Papulopustular Rosacea

United States

Clinical Trials Sponsored by Premier Health

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations